Literature DB >> 22786924

Use of healthcare resources after gestational diabetes mellitus: a longitudinal case-control analysis.

Eva Anderberg1, Katarina Steen Carlsson, Kerstin Berntorp.   

Abstract

AIMS: To analyse whether gestational diabetes mellitus (GDM) was associated with increases in healthcare utilisation after delivery.
METHODS: A longitudinal case-control registry-based study of 579 women with GDM delivered in 1995-2001. Two controls for each case were selected from the Swedish National Board of Health and Welfare, matched for year of birth, year of delivery, and municipality of residence. Data regarding healthcare utilisation was provided by the Patients' Administrative System in Skåne County, Sweden, covering the period from the years of delivery up to year 2009.
RESULTS: Women with previous GDM had higher mean number of contacts and total cost in the years after delivery as compared to controls, also when excluding utilisation related to subsequent pregnancies and childbirth. By year 2009, 31% of women with prior GDM were diagnosed with diabetes, compared to 1% of controls. Women diagnosed with diabetes were more likely to use health care (odds ratio 14.22, 95% confidence interval 5.87-34.45) controlling for age and time since delivery, whereas cases not diagnosed with diabetes did not differ from controls. The average annual cost of healthcare utilisation was 101% higher (p<0.001) for women with diabetes 10 years after delivery compared to controls.
CONCLUSIONS: GDM was associated with higher healthcare utilisation postpartum for women who had a diabetes diagnosis. The results call for implementation of structured programmes to follow up women with GDM postpartum for early detection of diabetes and effective management, which may have the potential for improved health and savings in healthcare costs.

Entities:  

Mesh:

Year:  2012        PMID: 22786924     DOI: 10.1177/1403494812449923

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  7 in total

1.  Continued Disparities in Postpartum Follow-Up and Screening Among Women With Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Systematic Review.

Authors:  Emily J Jones; Teri L Hernandez; Joyce K Edmonds; Erin P Ferranti
Journal:  J Perinat Neonatal Nurs       Date:  2019 Apr/Jun       Impact factor: 1.638

2.  The absolute and relative risk of type 2 diabetes after gestational diabetes: A systematic review and meta-analysis of 129 studies.

Authors:  Rebecca A Dennison; Eileen S Chen; Madeline E Green; Chloe Legard; Deeya Kotecha; George Farmer; Stephen J Sharp; Rebecca J Ward; Juliet A Usher-Smith; Simon J Griffin
Journal:  Diabetes Res Clin Pract       Date:  2020-12-15       Impact factor: 5.602

Review 3.  The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis.

Authors:  Katrien Benhalima; Karen Lens; Jan Bosteels; Mathieu Chantal
Journal:  J Clin Med       Date:  2019-09-10       Impact factor: 4.241

4.  Incidence Rate of Type 2 Diabetes Mellitus after Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of 170,139 Women.

Authors:  Zhuyu Li; Yunjiu Cheng; Dongyu Wang; Haitian Chen; Hanqing Chen; Wai-Kit Ming; Zilian Wang
Journal:  J Diabetes Res       Date:  2020-04-27       Impact factor: 4.011

5.  Cost Effectiveness of Antenatal Lifestyle Interventions for Preventing Gestational Diabetes and Hypertensive Disease in Pregnancy.

Authors:  Cate Bailey; Helen Skouteris; Cheryce L Harrison; Jacqueline Boyle; Rebeccah Bartlett; Briony Hill; Shakila Thangaratinam; Helena Teede; Zanfina Ademi
Journal:  Pharmacoecon Open       Date:  2020-09

Review 6.  Risk of type 2 diabetes mellitus after gestational diabetes mellitus: A systematic review & meta-analysis.

Authors:  Huaxuan You; Juan Hu; Ying Liu; Biru Luo; Anjiang Lei
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

7.  Economic burden of maternal morbidity - A systematic review of cost-of-illness studies.

Authors:  Patrick S Moran; Francesca Wuytack; Michael Turner; Charles Normand; Stephanie Brown; Cecily Begley; Deirdre Daly
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.